The original article [1] contained a minor error in the Additional file which has since been corrected.

1. 1.

   Wang C, et al. Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol. 2021;14:106. https://doi.org/10.1186/s13045-021-01120-3.

   CAS Article PubMed PubMed Central Google Scholar

Download references

1. Jing Nie and Weidong Han jointly supervise this work

2. Chunmeng Wang and Fengxia Shi are co-first author

Affiliations

1. Department of Bio-Therapeutic, The First Medical Centre in Chinese PLA General Hospital, Beijing, China

   Chunmeng Wang, Fengxia Shi, Yang Liu, Yajing Zhang, Liang Dong, Xiang Li, Chuan Tong, Yao Wang, Jing Nie & Weidong Han

2. Department of Hematology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China

   Liping Su

1. Chunmeng WangView author publications

   You can also search for this author in PubMed Google Scholar

2. Fengxia ShiView author publications

   You can also search for this author in PubMed Google Scholar

3. Yang LiuView author publications

   You can also search for this author in PubMed Google Scholar

4. Yajing ZhangView author publications

   You can also search for this author in PubMed Google Scholar

5. Liang DongView author publications

   You can also search for this author in PubMed Google Scholar

6. Xiang LiView author publications

   You can also search for this author in PubMed Google Scholar

7. Chuan TongView author publications

   You can also search for this author in PubMed Google Scholar

8. Yao WangView author publications

   You can also search for this author in PubMed Google Scholar

9. Liping SuView author publications

   You can also search for this author in PubMed Google Scholar

10. Jing NieView author publications

    You can also search for this author in PubMed Google Scholar

11. Weidong HanView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jing Nie or Weidong Han.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Cite this article

Wang, C., Shi, F., Liu, Y. et al. Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol 14, 150 (2021). https://doi.org/10.1186/s13045-021-01154-7

Download citation

• Published: 23 September 2021

• DOI: https://doi.org/10.1186/s13045-021-01154-7

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative